Study of Lopinavir/ Ritonavir and Lamivudine Versus Standard Therapy in Naïve HIV-1 Infected Subjects.

NCT01237444 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

417

Enrollment

OTHER

Sponsor class

Conditions

HIV Infection

Interventions

DRUG: lopinavir/ritonavir plus one nucleoside
DRUG: lopinavir /ritonavir plus two nucleosides

Sponsor

Pedro Cahn

Collaborators

[object Object]